Pleural mesothelioma malignant advanced
Clinical trials for Pleural mesothelioma malignant advanced explained in plain language.
Never miss a new study
Get alerted when new Pleural mesothelioma malignant advanced trials appear
Sign up with your email to follow new studies for Pleural mesothelioma malignant advanced, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an immunotherapy drug outperform chemotherapy for mesothelioma?
Disease control CompletedThis trial compares two treatments for people with advanced malignant pleural mesothelioma, a cancer of the lining of the lungs, that has progressed after initial chemotherapy. Half of the participants receive pembrolizumab, an immunotherapy that helps the immune system fight can…
Matched conditions: PLEURAL MESOTHELIOMA MALIGNANT ADVANCED
Phase 3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New combo therapy shows promise for rare lung cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard treatment (bevacizumab plus chemotherapy) helps people with advanced malignant pleural mesothelioma live longer. The trial involved 400 adults whose cancer could not be removed by surgery. Researcher…
Matched conditions: PLEURAL MESOTHELIOMA MALIGNANT ADVANCED
Phase 3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC